The funding program supported the development of three different vaccines.The European Medicines Agency (EMA) granted conditional approval for BioNTech's vaccine on December 21, 2020.Since then, several billion doses were produced and used worldwide.Thus, the German RRP sponsored vaccine has been instrumental in mitigating the social and economic consequences of the pandemic.More information can be found on the website of the government hereTop 100 recipientsBioNTech SE Reference5.1.3.Project locations Germany Project websitewww.bundesfinanzministerium.de/
